Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by HIROMITSU KISHIMOTO
The Hippo Pathway Transcriptional Co-Activator, YAP, Confers Resistance to Cisplatin in Human Oral Squamous Cell Carcinoma
International Journal of Oncology
Cancer Research
Oncology
Functional Analysis of Zyxin in Cell Migration and Invasive Potential of Oral Squamous Cell Carcinoma Cells
International Journal of Oncology
Cancer Research
Oncology
Related publications
The Characteristic of S100A7 Induction by the Hippo-Yap Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma
PLoS ONE
Multidisciplinary
Cisplatin-Resistance in Oral Squamous Cell Carcinoma: Regulation by Tumor Cell-Derived Extracellular Vesicles
Cancers
Cancer Research
Oncology
Hepatocyte Nuclear Factor 4 Alpha Overexpression Confers Resistance to Radiation in a Human Oral Cavity Squamous Cell Carcinoma Cell Line
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
circRNA_0000140 Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting miR-31 to Inhibit Hippo Signaling Pathway
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Copper Efflux Transporter (ATP7B) Contributes to the Acquisition of Cisplatin-Resistance in Human Oral Squamous Cell Lines
Oncology Reports
Medicine
Cancer Research
Oncology
YAP Induces Cisplatin Resistance Through Activation of Autophagy in Human Ovarian Carcinoma Cells
OncoTargets and Therapy
Oncology
Pharmacology
P075 Hippo-Yap Pathway Mediated Resistance to Crizotinib in ROS1-Positive Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
RUNX3 Reverses Cisplatin Resistance in Esophageal Squamous Cell Carcinoma via Suppression of the Protein Kinase B Pathway
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Energy Stress Regulates the Hippo-Yap Pathway
Cancer Discovery
Oncology